C. Lange (Borstel, Germany), D. Goletti (Roma, Italy)
Detection of latent tuberculosis in a low-prevalence country
A. Browatzki, C. N. Meyer (Roskilde, Denmark)
|   |
Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis
Y. Kobashi, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan)
| |
The results of QuantiFERON-TB testing among the symptomatic patients in Brasov, Romania
I. Muntean, C. Macavei, D. Frosin, V. Juganaru, M. V. Macavei, R. Macavei (Brasov, Bucharest, Romania)
| |
Evaluation of usefulness of QuantiFERON®-TB Gold for infants
N. Harada, T. Miyakawa, K. Higuchi, M. Suenaga, T. Mori (Tokyo, Japan)
| |
The value of cellular interferon – gamma assays for TB diagnosis in immunocompetent and immunocompromised patients
O. A. Caliman-Sturdza, N. C. Bilha (Suceava, Romania)
| |
Rates of latent tuberculosis infection among medical staff in a TB hospital from Brasov, Romania
I. Muntean, C. Macavei, M. V. Macavei, R. Macavei, H. Lapusan, M. Lascu (Brasov, Bucharest, Romania)
| |
Comparison between the antigen-specific interferon-gamma assay and the tuberculin skin testing for the detection of tuberculosis infection among BCG vaccinated schoolers at risk for tuberculosis exposure
O. C. Arghir, M. Ghelberg, G. Voicu (Constantza, Romania)
| |
Reduced dropout rate with interferon-γ release assays compared to tuberculin skin test for TB screening
P. Sestini, S. Kouki, G. Ciarleglio, L. Mori, M. Refini, O. Bugiani (Siena, Italy)
| |
Our experience of T cell assays in the diagnosis of MTB disease and latent infection
L. Powell, S. Marciniak, R. Mulla, P. Kanthapillai (Luton, United Kingdom)
| |
Using an interferon-γ assay for the diagnosis of tuberculosis infection before using tumor necrosis factor-α blockers
N. Cobanoglu, U. Ozcelik, U. Kalyoncu, S. Ozen, S. Kiraz, N. Gurcan, M. Kaplan, D. Dogru, E. Yalcin, S. Pekcan, M. Kose, R. Topaloglu, N. Besbas, A. Bakkaloglu, N. Kiper (Ankara, Turkey)
| |
A new assay for the diagnosis of tuberculosis infection in an unselected population
I. Gerogianni, M. Papala, D. Klapsa, E. Zinzaras, E. Petinaki, K. Gourgoulianis (Larissa, Greece)
| |
The value of interferon (IFN)-γ blood tests in diagnosis of tuberculosis
P. Kapisyzi, E. Grabocka, E. Petrela, J. Bukli, J. Gjirazi (Tirana, Albania; Tirana, Andorra)
| |
Performance of RD-1 based blood assays in clinical management of smear-negative pulmonary and extra-pulmonary tuberculosis
M. Bocchino, B. Bellofiore, A. Matarese, P. Giacomelli, A. Russo, G. Signoriello, D. Galati, A. Sanduzzi (Naples, Italy)
| |
The value of interferon (IFN)-γ pleural effusion tests in diagnosis of tuberculosis
J. Bukli, E. Petrela, J. Gjirazi, D. Argjiri, Y. Vakeflliu, P. Kapisyzi (Tirana, Albania)
| |
Effect of isoniazid prophylaxis for latent TB on interferon-gamma response
B. Kipfer, C. Maier, M. Büchler, T. Bodmer (Thun, Bern, Switzerland)
| |
Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment
S. Arun, S. K. Katiyar, S. Bihari (Kanpur, India)
| |
Association with TB exposure of tuberculin skin test and interferon-γ release assays. A systematic review
G. Ciarleglio, S. Kouki, L. Mori, M. Kouri, O. Bugiani, P. Sestini (Siena, Italy)
| |
Interferon-γ release assays using RD1 antigens in nontuberculous mycobacterial infections. A systematic review
L. Mori, S. Kouki, G. Ciarleglio, M. Pieroni, O. Bugiani, P. Sestini (Siena, Italy)
| |
Comparison of the tuberculin skin test and two commercial blood tests for diagnosing active mycobacterium tuberculosis infection and nontuberculous mycobacterium infection
Y. Kobashi, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Okayama, Japan)
| |
Interferon-γ release assays in the diagnosis of pulmonary tuberculosis: a systematic review
S. Kouki, L. Mori, G. Ciarleglio, R. M. Refini, O. Bugiani, P. Sestini (Siena, Italy)
| |